Filter News
Area of Research
- (-) Supercomputing (22)
- Biology and Environment (20)
- Computational Biology (1)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Energy Science (81)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion and Fission (4)
- Isotopes (1)
- Materials (38)
- Materials for Computing (7)
- National Security (4)
- Neutron Science (16)
- Nuclear Science and Technology (1)
News Topics
- (-) Coronavirus (14)
- (-) Energy Storage (8)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (1)
- Artificial Intelligence (37)
- Big Data (22)
- Bioenergy (9)
- Biology (11)
- Biomedical (17)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (5)
- Computer Science (96)
- Critical Materials (3)
- Cybersecurity (8)
- Environment (22)
- Exascale Computing (26)
- Frontier (32)
- Fusion (1)
- Grid (5)
- High-Performance Computing (43)
- Isotopes (2)
- Machine Learning (15)
- Materials (15)
- Materials Science (16)
- Mathematics (2)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (8)
- Neutron Science (13)
- Nuclear Energy (4)
- Partnerships (1)
- Physics (8)
- Polymers (2)
- Quantum Computing (20)
- Quantum Science (24)
- Security (6)
- Simulation (16)
- Software (1)
- Space Exploration (3)
- Summit (43)
- Transportation (6)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 22 Results

As current courses through a battery, its materials erode over time. Mechanical influences such as stress and strain affect this trajectory, although their impacts on battery efficacy and longevity are not fully understood.

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

A new paper published in Nature Communications adds further evidence to the bradykinin storm theory of COVID-19’s viral pathogenesis — a theory that was posited two years ago by a team of researchers at the Department of Energy’s Oak Ridge National Laboratory.

When Hurricane Maria battered Puerto Rico in 2017, winds snapped trees and destroyed homes, while heavy rains transformed streets into rivers. But after the storm passed, the human toll continued to grow as residents struggled without electricity for months. Five years later, power outages remain long and frequent.

Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.

The Frontier supercomputer at the Department of Energy’s Oak Ridge National Laboratory earned the top ranking today as the world’s fastest on the 59th TOP500 list, with 1.1 exaflops of performance. The system is the first to achieve an unprecedented level of computing performance known as exascale, a threshold of a quintillion calculations per second.

ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.

To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.

A world-leading researcher in solid electrolytes and sophisticated electron microscopy methods received Oak Ridge National Laboratory’s top science honor today for her work in developing new materials for batteries. The announcement was made during a livestreamed Director’s Awards event hosted by ORNL Director Thomas Zacharia.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.